Jacqueline Cloos

PROF.DR., (Principal Investigator)

  • Amsterdam UMC, Vrije Universiteit Amsterdam, Hematology Laboratory, Cancer Center Amsterdam, De Boelelaan 1117 Amsterdam The Netherlands

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2020

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK), 1 Jan 2020, In : Leukemia.

Research output: Contribution to journalArticleAcademicpeer-review

Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes

Hanekamp, D., Bachas, C., van de Loosdrecht, A., Ossenkoppele, G. & Cloos, J., 2020, In : Pathology. 52, 2, p. 289-291

Research output: Contribution to journalComment/Letter to the editorAcademic

Can we incorporate MRD assessment into clinical practice in AML?

Ossenkoppele, G., Schuurhuis, G. J., van de Loosdrecht, A. & Cloos, J., 1 Jun 2019, In : Best Practice and Research: Clinical Haematology. 32, 2, p. 186-191 6 p.

Research output: Contribution to journalReview articleAcademicpeer-review

CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia

Zeijlemaker, W., Grob, T., Meijer, R., Hanekamp, D., Kelder, A., Carbaat-Ham, J. C., Oussoren-Brockhoff, Y. J. M., Snel, A. N., Veldhuizen, D., Scholten, W. J., Maertens, J., Breems, D. A., Pabst, T., Manz, M. G., van der Velden, V. H. J., Slomp, J., Preijers, F., Cloos, J., van de Loosdrecht, A. A., Löwenberg, B. & 4 othersValk, P. J. M., Jongen-Lavrencic, M., Ossenkoppele, G. J. & Schuurhuis, G. J., 1 May 2019, In : Leukemia. 33, 5, p. 1102-1112

Research output: Contribution to journalArticleAcademicpeer-review